
Venlusk 75mg Tablet ER
Marketer
Sanix Formulation Pvt Ltd
Salt Composition
Venlafaxine (75mg)
Overview Venlusk 75mg Tablet ER
Venlusk 75mg Extended-Release tablets treat depression and anxiety. This medication modifies brain chemistry, addressing anxiety symptoms like restlessness, irritability, poor concentration, tiredness, sweating, rapid heartbeat, and racing thoughts. Take Venlusk 75mg ER with food at the same time daily for consistent blood levels. Missed doses should be taken immediately upon recall; complete the prescribed course, even if feeling improved. Abrupt cessation may exacerbate symptoms. Possible side effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, excessive sweating, and sexual difficulties. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the effects are known. Most side effects are transient. Consult your physician if side effects persist or are bothersome. Prior to starting Venlusk 75mg ER, disclose any kidney, heart, or liver issues, or history of seizures to your doctor. Report any unusual mood shifts, worsening depression, or suicidal ideation immediately.
Primary Ingredients of Venlusk 75mg Tablet ER
No information provided. A rephrased version cannot be created.
Uses of Venlusk 75mg Tablet ER
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Venlusk 75mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Venlusk 75mg Extended-Release Tablet with food.
Common Side effects of Venlusk 75mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Venlusk 75mg Tablet ER:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Venlusk 75mg Extended-Release Tablet with food.
How Venlusk 75mg Tablet ER works:
Extended-release Venlusk 75mg tablets function by elevating brain concentrations of serotonin and noradrenaline, neurotransmitters crucial for preserving emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Venlusk 75mg Extended-Release tablets and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Venlusk 75mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Venlusk 75mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and satisfactory weight increase is recommended.
DrivingUNSAFE
Driving ability may be impaired by Venlusk 75mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving skills.
KidneyCAUTION
Extended-release Venlusk 75mg tablets require careful administration for individuals with impaired renal function. Dosage modification of Venlusk 75mg ER tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Venlusk 75mg Extended-Release tablets. Dosage modification of Venlusk 75mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Venlusk 75mg Tablet ER :
Should you forget a Venlusk 75mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Venlusk 75mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Action Class | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
